Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection
Authors
Keywords
-
Journal
Nanomedicine-Nanotechnology Biology and Medicine
Volume 39, Issue -, Pages 102463
Publisher
Elsevier BV
Online
2021-09-27
DOI
10.1016/j.nano.2021.102463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin
- (2020) Elena A. Blokhina et al. Plants-Basel
- Development of a Universal Influenza Vaccine
- (2019) Leonardo D. Estrada et al. JOURNAL OF IMMUNOLOGY
- The Role of M2e in the Development of Universal Influenza Vaccines
- (2019) Xavier Saelens JOURNAL OF INFECTIOUS DISEASES
- Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
- (2016) Saranya Sridhar Frontiers in Immunology
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency
- (2015) Nikolai V. Ravin et al. VACCINE
- Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
- (2015) Yu-Na Lee et al. Immune Network
- Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
- (2015) Liudmila A. Stepanova et al. PLoS One
- The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
- (2013) Jianjun Chen et al. BIOMATERIALS
- A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
- (2012) Elena A. Blokhina et al. VIROLOGY
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
- (2010) T. T. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
- (2009) Michael Schotsaert et al. Expert Review of Vaccines
- A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria
- (2009) S. A. Kaba et al. JOURNAL OF IMMUNOLOGY
- M2e-based universal influenza A vaccine
- (2009) Walter Fiers et al. VACCINE
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine
- (2008) Tais A. P. F. Pimentel et al. Chemical Biology & Drug Design
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now